Grants AwardedDr. Tobin will test strategies to optimize cutting-edge gene and drug therapies by selectively targeting the most severely affected cells and brain networks in a mouse model of KCNT1-related epilepsy.
Grants AwardedThe goal of this project is to conduct a proof-of-principle study to determine if early treatment with a novel catalytic antioxidant prevents metabolic dysfunction and epilepsy in mice lacking a critical mitochondrial antioxidant.
Grants AwardedOur ability to test potential therapies directly on tissue from an affected child as well as on neurons expressing the same genetic mutation as that child will pave the way for the application of “personalized medicine” techniques to the treatment of intractable pediatric epilepsy.
Grants AwardedThe goal of Drs. Perez-Reyes and Kapur’s research is to develop a novel gene therapy tool that will silence hyperactive neurons that cause seizures by selective expression of a potassium leak channel.
Grants AwardedWe propose to test the hypothesis that virus infection activates the complement system in the brain that in turn increases inflammation which ultimately contributes to the development of seizures.